Titlebook: Breast Cancer Treatment: An Interdisciplinary Approach; Nima Rezaei Book 2024 The Editor(s) (if applicable) and The Author(s), under exclu

淹沒

書目名稱Breast Cancer Treatment: An Interdisciplinary Approach影響因子(影響力)




書目名稱Breast Cancer Treatment: An Interdisciplinary Approach影響因子(影響力)學科排名




書目名稱Breast Cancer Treatment: An Interdisciplinary Approach網(wǎng)絡公開度




書目名稱Breast Cancer Treatment: An Interdisciplinary Approach網(wǎng)絡公開度學科排名




書目名稱Breast Cancer Treatment: An Interdisciplinary Approach被引頻次




書目名稱Breast Cancer Treatment: An Interdisciplinary Approach被引頻次學科排名




書目名稱Breast Cancer Treatment: An Interdisciplinary Approach年度引用




書目名稱Breast Cancer Treatment: An Interdisciplinary Approach年度引用學科排名




書目名稱Breast Cancer Treatment: An Interdisciplinary Approach讀者反饋




書目名稱Breast Cancer Treatment: An Interdisciplinary Approach讀者反饋學科排名

館長

Triple-Negative Breast Cancer Therapy: Recent Advances, Challenges, and Future Perspective,d therapy for TNBC is challenging. Chemotherapy, radiation therapy, and surgical resection are the existing treatment options for TNBC. Chemotherapy is sensitive to TNBC; however, development of resistance mechanisms and recurrence remain the major reasons of treatment failure in patient with TNBC.

Estrogen

Advances in Local Ablative Techniques for Breast Cancer,ant mastectomies, which often led to significant physical and psychological morbidity, the focus has shifted to breast-conserving surgery and minimally invasive ablative techniques..This chapter provides a comprehensive review of the various ablative modalities available for breast cancer management

多產魚

流利圓滑

podiatrist

Insufficient

Updates on the Management of Ductal Carcinoma In Situ of the Breasts,rement. Adjuvant radiotherapy is usually advised in patients who received lumpectomy. However, over the last decades, de-escalating DCIS treatment has been a debatable topic. Ongoing randomized controlled trials (RCTs) are now in progress to evaluate whether or not we could safely omit surgery in se

預測

Nanostructured Lipid Carrier as a Strategy for the Treatment of Breast Cancer,of deaths annually worldwide. Conventional treatment, although clinically effective, is associated with the development of resistance in more advanced stages of the disease and high toxicity in healthy cells, leading to a poor prognosis. Furthermore, the active compounds that represent these therape

真繁榮

Managing Breast Cancer Using the Cell-Surface GRP78,tment of breast cancer, there is a need for more effective management strategies..Different avenues emerged recently use the glucose-regulated protein 78 (GRP78) in cancer patients both in diagnosis and in treatment. In addition to managing the unfolded protein response under the stress of the unfol

繁重